@rheum_cat @KDAO2011 @RheumEpi @JYazdanyMD @RADoctor That too... so many great moments in this video... also this reaction --> 😕 😂😂😂 @alhkim https://t.co/kAYBgPk1aB

When you sign up to bike the ACR Virtual 5k, but it’s 62 degrees and beautiful in MN in November, you keep going and make it 20k.#acr21 #RheumPix https://t.co/j1Smoga41r

and for those interested in the detail: - remnant TAB divided and culture ex vivo with placebo, mavrilimumab, tocilizumab - inflamm transcriptomics panel - 81 differentially expressed genes assessed - categorised by function https://t.co/0MWZk82Gj5

Great start to #ACR21 and great recap of the year in rheumatology. Positive data on tofacitinib and AS but still pending approval. Where would JAKinibs be in your AS treatment algorithm?🤔 @RheumNow https://t.co/cs8U33355A

#ACR21 Abst#0910 by @rheum_cat. Do TNFi ⬆️ risk of incident HTN in AxSpa? ⭐️PSOAS cohort: Prosp study from 2003-2018 ▶️When adjusted for confounders (obesity, disease activity, NSAID use), insufficient evidence to show ⬆️ risk of HTN w TNFi https://t.co/DCZ3W8CkOa @Rheumnow

• https://bit.ly/3ESM4ji

Exciting day at #ACR21 I wrote an article discussing COVID 19 in #RheumatoidArthritis discussing the following abstracts 0097 by Hasseli 1445 by @NamrataRheum L04 by @rheum_cat & @rheum_covid @rheumnow #COVID19 #RA #JAK #Rituximab https://t.co/g32ZYHBjQY

• Outcomes of COVID-19 in Patients with Rheumatoid Arthritis | RheumNow

#ACR21 Abst#0916. https://t.co/uc5JDVY0ud Your patient has had 1 yr of remission of AxSpa on Certolizumab pegol, tolerating the medication. What do you recommend @Rheumnow

• https://bit.ly/3COeIRU

Dr. Thaissa Cotton on SLE + ILD and/or myositis: important given poorer outcomes. Ask pts and listen to those lungs! 💠1.8 cases/100 patient years (14/551 pts in study) 💠92.9% had >=1 med-to-high titer marker 💠⬆️risk if baseline +anti KL-6, Ku, CENPB #ACR21 Abst#0330 @RheumNow

#ACR21 Abst#0916 ⭐️AxSpa pts in remission: Full Certolizumab vs 1/2 dose vs PBO ▶️ 85% w/o flare in full dose, 80% in 1/2 dose, just 23% in PBO ▶️ PBO pts with NO flare STILL showed ⬆️ ASDAS, BASDAI, and CRP 🔥Would ⬇️ not d/c Cimzia! @Rheumnow https://t.co/uc5JDVY0ud #ACRBest https://t.co/fOssPlTEwR

• https://bit.ly/3COeIRU